Spread the word The National Agency for Food and Drug Administration and Control (NAFDAC) has warned healthcare providers, patients and the general public about the circulation of falsified and parallel imported versions of Dostinex 0.5mg tablets in Nigeria. The agency stated this in a public alert published on its website, Tuesday. NAFDAC said Pfizer Nigeria Ltd, the Marketing Authorisation Holder (MAH) of the product, confirmed the presence of falsified and parallel unregistered imported versions in the country. Although, the company noted that the original product has been duly registered by NAFDAC, it has not yet been officially imported into Nigeria. Dostinex 0.5mg Tablets, manufactured by Pfizer Italia S.R.L, are used to reduce prolactin secretion and manage conditions associate...